Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3400298
Max Phase: Preclinical
Molecular Formula: C36H60N16O9
Molecular Weight: 860.98
Molecule Type: Small molecule
Associated Items:
ID: ALA3400298
Max Phase: Preclinical
Molecular Formula: C36H60N16O9
Molecular Weight: 860.98
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)[C@H](CO)NC(=O)CCCCCn1cc(CN(Cc2cn(CCCCCC(=O)N[C@@H](CO)C(N)=O)nn2)Cc2cn(CCCCCC(=O)N[C@@H](CO)C(N)=O)nn2)nn1
Standard InChI: InChI=1S/C36H60N16O9/c37-34(59)28(22-53)40-31(56)10-4-1-7-13-50-19-25(43-46-50)16-49(17-26-20-51(47-44-26)14-8-2-5-11-32(57)41-29(23-54)35(38)60)18-27-21-52(48-45-27)15-9-3-6-12-33(58)42-30(24-55)36(39)61/h19-21,28-30,53-55H,1-18,22-24H2,(H2,37,59)(H2,38,60)(H2,39,61)(H,40,56)(H,41,57)(H,42,58)/t28-,29-,30-/m0/s1
Standard InChI Key: FEKBXEVQDBAPQV-DTXPUJKBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 860.98 | Molecular Weight (Monoisotopic): 860.4729 | AlogP: -3.77 | #Rotatable Bonds: 33 |
Polar Surface Area: 372.63 | Molecular Species: NEUTRAL | HBA: 19 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 25 | HBD (Lipinski): 12 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.38 | CX Basic pKa: 2.11 | CX LogP: -4.74 | CX LogD: -4.74 |
Aromatic Rings: 3 | Heavy Atoms: 61 | QED Weighted: 0.03 | Np Likeness Score: -0.50 |
1. Elshan NG, Jayasundera T, Weber CS, Lynch RM, Mash EA.. (2015) Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor., 23 (8): [PMID:25769518] [10.1016/j.bmc.2015.02.028] |
Source(1):